FEDERATED MORPHOMETRY FEATURE SELECTION FOR HIPPOCAMPAL MORPHOMETRY ASSOCIATED BETA-AMYLOID AND TAU PATHOLOGY
Jianfeng Wu(Xijing Hospital), Jieping Ye(Alibaba Group (China)), Eric M. Reiman(Alzheimer's Association), Natasha Leporé(University of Southern California), Qunxi Dong(Arizona State University), Teresa Wu(Arizona State University), Yi Su(University of Electronic Science and Technology of China), Kewei Chen(Good Samaritan Medical Center), Jie Zhang(Indiana University – Purdue University Indianapolis), Paul M. Thompson(University of Southern California), Yalin Wang(University of Notre Dame), Richard J. Caselli(Mayo Clinic in Arizona)
Cited by 2
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM)
|Philosophical Transactions of the Royal Society B Biological Sciences|2001|2.4k
Mapping cortical change across the human life span
|Nature Neuroscience|2003|2.3k